Evaluating a digital tool for supporting breast cancer patients: a randomized controlled trial protocol (ADAPT).

ABSTRACT:

Background

There are a growing number of mHealth tools for breast cancer patients but a lack of scientific evidence for their effects. Recent studies have shown a mix of positive and negative impacts on users. Here we will assess the impact of OWise Breast Cancer, a mobile application for self-monitoring symptoms and managing care, on the process of self-management.

Methods

This randomized controlled trial with early stage breast cancer patients will assess the effect of OWise use on patient activation at 3 months from diagnosis measured by the PAM-13 questionnaire. We will also assess differences in changes in health-related quality of life, psychological distress, health status, and National Health Service (NHS) health resource utilization over the first year from diagnosi

SUBMITTER: Lidington E 

PROVIDER: S-EPMC6961395 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature